Welcome to the 10th Anniversary of the 2018 PDA Europe Conference on Advanced Therapy Medicinal Products (ATMPs)!
It is with great pleasure for us to present you with an outstanding conference agenda and training course over the next few days in Amsterdam.
PDA prides itself in connecting people, science and regulation. The following three days should provide you with ample opportunity to do exactly that.
Please take advantage of the impressive panel of speakers and come introduce yourself to us, the Chairs of this meeting as well as our fellow planning committee members, and your fellow attendees.
Over the past ten years, PDA Europe’s ATMPs conference has become a fixture in the calendar of professionals working in the field of cell and gene-therapy-based drug products. It has reliably offered all participants an open forum for exchange of current best-practice approaches all along the path from R&D through Manufacturing to the clinical application of Advanced Therapies and Medicinal Products.
Handling, testing, and quality control of raw materials, novel approaches to flexible facilities, a thorough update and review of EU GMP Regulations for ATMPs as well as a look at Organ-on-Chip technologies and their relevance for the future of cell and gene therapies will be only some of the highlights in this very special two-day program.
Joint lunches, coffee breaks and a fun Networking Event all aim to facilitate connecting you with the PDA family!
We look forward to spending two amazing conference days with you in Amsterdam!
Lutz Uharek, Prof. Dr.,
Head of the Stem Cell Facility, Charité Berlin
Wilfried Dalemans, PhD, Chief Technical Officer, TiGenix